Cutting edge: FcR-like 5 on innate B cells is targeted by a poxvirus MHC class I-like immunoevasin

Journal of Immunology

Volumn 185, Issue 1, 2010, Pages 28-32

  Campbell, Jessica A ^a   Davis, Randall S ^b,c,d   Lilly, Lauren M ^c   Fremont, Daved H ^a   French, Anthony R ^a   Carayannopoulos, Leonidas N ^a,e  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b University of Alabama at Birmingham   (United States)

^c University of Alabama at Birmingham   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^e MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FCR LIKE 5 PROTEIN; IMMUNOEVASIN; IMMUNOGLOBULIN; IMMUNOMODULATING AGENT; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NATURAL KILLER CELL RECEPTOR NKG2D; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; FC RECEPTOR; FCRH3 PROTEIN, MOUSE; HLA ANTIGEN CLASS 1; KLRK1 PROTEIN, MOUSE; LIGAND; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY K; VIRUS PROTEIN;

AMINO TERMINAL SEQUENCE; ANTIGEN RECOGNITION; ARTICLE; B LYMPHOCYTE; BINDING AFFINITY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE TARGETING; HOST RESISTANCE; HUMAN; HUMAN CELL; IMMUNITY; IMMUNOREGULATION; MACROPHAGE; MONOCYTE; NATURAL KILLER CELL; NONHUMAN; ORTHOPOXVIRUS; POXVIRUS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN TARGETING; T LYMPHOCYTE SUBPOPULATION; ZOONOSIS; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CELL LINE; GENETICS; IMMUNE EVASION; IMMUNOLOGY; INNATE IMMUNITY; METABOLISM; MOUSE; PATHOGENICITY; PHYSIOLOGY; TUMOR CELL LINE; VIROLOGY;

ANIMALS; B-LYMPHOCYTE SUBSETS; CELL LINE; CELL LINE, TUMOR; GENE TARGETING; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNE EVASION; IMMUNITY, INNATE; LIGANDS; MACROPHAGES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MONOCYTES; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K; ORTHOPOXVIRUS; PROTEIN BINDING; RECEPTORS, FC; VIRAL PROTEINS;

EID: 77956206644     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1000240     Document Type: Article

References (25)

1. Campbell, J. A., D. S. Trossman, W. M. Yokoyama, and L. N. Carayannopoulos. 2007. Zoonotic orthopoxviruses encode a high-affinity antagonist of NKG2D. J. Exp. Med. 204: 1311-1317.
2. Fang, M., L. L. Lanier, and L. J. Sigal. 2008. A role for NKG2D in NK cell-mediated resistance to poxvirus disease. PLoS Pathog. 4: e30.
3. Houchins, J. P., T. Yabe, C. McSherry, and F. H. Bach. 1991. DNA sequence analysis of NKG2, a family of related cDNA clones encoding type II integral membrane proteins on human natural killer cells. J. Exp. Med. 173: 1017-1020.
4. Bauer, S., V. Groh, J. Wu, A. Steinle, J. H. Phillips, L. L. Lanier, and T. Spies. 1999. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 285: 727-729. (Pubitemid 129505074)
5. Diefenbach, A., A. M. Jamieson, S. D. Liu, N. Shastri, and D. H. Raulet. 2000. Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages. Nat. Immunol. 1: 119-126.
6. Morita, S., T. Kojima, and T. Kitamura. 2000. Plat-E: an efficient and stable system for transient packaging of retroviruses. Gene Ther. 7: 1063-1066.
7. Carayannopoulos, L. N., O. V. Naidenko, D. H. Fremont, and W. M. Yokoyama. 2002. Cutting edge: murine UL16-binding protein-like transcript 1: a newly described transcript encoding a high-affinity ligand for murine NKG2D. J. Immunol. 169: 4079-4083.
8. Nybakken, G. E., T. Oliphant, S. Johnson, S. Burke, M. S. Diamond, and D. H. Fremont. 2005. Structural basis of West Nile virus neutralization by a therapeutic antibody. Nature 437: 764-769.
9. Won, W. J., J. B. Foote, M. R. Odom, J. Pan, J. F. Kearney, and R. S. Davis. 2006. Fc receptor homolog 3 is a novel immunoregulatory marker of marginal zone and B1 B cells. J. Immunol. 177: 6815-6823.
10. Baba, T., A. Ishizu, S. Iwasaki, A. Suzuki, U. Tomaru, H. Ikeda, T. Yoshiki, and M. Kasahara. 2006. CD4+/CD8+ macrophages infiltrating at inflammatory sites: a population of monocytes/macrophages with a cytotoxic phenotype. Blood 107: 2004-2012.
11. Buhtoiarov, I. N., A. L. Rakhmilevich, L. L. Lanier, E. A. Ranheim, and P. M. Sondel. 2009. Naive mouse macrophages become activated following recognition of L5178Y lymphoma cells via concurrent ligation of CD40, NKG2D, and CD18 molecules. J. Immunol. 182: 1940-1953.
12. Davis, R. S., R. P. Stephan, C. C. Chen, G. Dennis, Jr., and M. D. Cooper. 2004. Differential B cell expression of mouse Fc receptor homologs. Int. Immunol. 16: 1343-1353.
13. Mohan, J., J. Dement-Brown, S. Maier, T. Ise, B. Kempkes, and M. Tolnay. 2006. Epstein-Barr virus nuclear antigen 2 induces FcRH5 expression through CBF1. Blood 107: 4433-4439.
14. Xu, M. J., R. Zhao, H. Cao, and Z. J. Zhao. 2002. SPAP2, an Ig family receptor containing both ITIMs and ITAMs. Biochem. Biophys. Res. Commun. 293: 1037-1046.
15. Haga, C. L., G. R. Ehrhardt, R. J. Boohaker, R. S. Davis, and M. D. Cooper. 2007. Fc receptor-like 5 inhibits B cell activation via SHP-1 tyrosine phosphatase recruitment. Proc. Natl. Acad. Sci. USA 104: 9770-9775.
16. Pillai, S., A. Cariappa, and S. T. Moran. 2005. Marginal zone B cells. Annu. Rev. Immunol. 23: 161-196.
17. Oliver, A. M., F. Martin, G. L. Gartland, R. H. Carter, and J. F. Kearney. 1997. Marginal zone B cells exhibit unique activation, proliferative and immunoglobulin secretory responses. Eur. J. Immunol. 27: 2366-2374.
18. Oliver, A. M., F. Martin, and J. F. Kearney. 1999. IgM high CD21 high lymphocytes enriched in the splenic marginal zone generate effector cells more rapidly than the bulk of follicular B cells. J. Immunol. 162: 7198-7207.
19. Boes, M., A. P. Prodeus, T. Schmidt, M. C. Carroll, and J. Chen. 1998. A critical role of natural immunoglobulin M in immediate defense against systemic bacterial infection. J. Exp. Med. 188: 2381-2386.
20. Baumgarth, N., J. Chen, O. C. Herman, G. C. Jager, and L. A. Herzenberg. 2000. The role of B-1 and B-2 cells in immune protection from influenza virus infection. Curr. Top. Microbiol. Immunol. 252: 163-169.
21. Baumgarth, N., O. C. Herman, G. C. Jager, L. Brown, L. A. Herzenberg, and L. A. Herzenberg. 1999. Innate and acquired humoral immunities to influenza virus are mediated by distinct arms of the immune system. Proc. Natl. Acad. Sci. USA 96: 2250-2255.
22. Choi, Y. S., and N. Baumgarth. 2008. Dual role for B-1a cells in immunity to influenza virus infection. J. Exp. Med. 205: 3053-3064.
23. Ochsenbein, A. F., T. Fehr, C. Lutz, M. Suter, F. Brombacher, H. Hengartner, and R. M. Zinkernagel. 1999. Control of early viral and bacterial distribution and disease by natural antibodies. Science 286: 2156-2159.
24. Martin, F., and J. F. Kearney. 2000. B-cell subsets and the mature preimmune repertoire. Marginal zone and B1 B cells as part of a "natural immune memory". Immunol. Rev. 175: 70-79.
25. Davis, R. S. 2007. Fc receptor-like molecules. Annu. Rev. Immunol. 25: 525-560.